Pages that link to "NCT02975336: Phase II Clinical Trial"
Jump to navigation
Jump to search
The following pages link to NCT02975336: Phase II Clinical Trial:
Displayed 7 items.
- NCT02975336 (redirect page) (← links)
- NCT02975336 Clinical Trial (redirect page) (← links)
- NCT02975336 Phase II Clinical Trial (redirect page) (← links)
- A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE (redirect page) (← links)
- NCT02975336: A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE (redirect page) (← links)
- NCT02975336 clinical trial (redirect page) (← links)
- A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE) (redirect page) (← links)